EU Considers Limiting Chinese Access to Public Procurement
(MENAFN) The European Union is reportedly contemplating new limits on public procurement contracts for Chinese medical device manufacturers, according to a report published by a news agency on Monday.
The information comes from a source familiar with the matter.
This move would potentially impact how Chinese firms engage with public sector projects across the EU.
Relations between Brussels and Beijing have grown increasingly tense, with both sides engaging in retaliatory measures linked to accusations of economic protectionism.
The trade friction has intensified over recent months, prompting broader scrutiny of commercial ties between the two powers.
Earlier this year, the European Commission disclosed that an investigation initiated in the previous year had found signs of discriminatory practices by China.
Specifically, the probe suggested that the Chinese government has been restricting access for EU-based medical device companies and other suppliers to its public procurement market.
In a related development, China’s Ministry of Commerce announced last month that it would extend its anti-dumping inquiry into EU brandy imports.
This investigation, which Beijing launched in reaction to an EU probe, has reportedly become more complicated, leading to the decision to prolong the review process.
According to the news agency’s source, representatives from the 27 EU member states are scheduled to cast their votes on the proposed restrictions on Monday, June 2. Should the measure be adopted, it would represent the EU’s inaugural use of the International Procurement Instrument (IPI).
This legal framework, introduced in 2022, aims to encourage fairness and mutual access in the realm of public procurement markets.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
